ECSP088079A - Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificado - Google Patents
Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificadoInfo
- Publication number
- ECSP088079A ECSP088079A EC2008008079A ECSP088079A ECSP088079A EC SP088079 A ECSP088079 A EC SP088079A EC 2008008079 A EC2008008079 A EC 2008008079A EC SP088079 A ECSP088079 A EC SP088079A EC SP088079 A ECSP088079 A EC SP088079A
- Authority
- EC
- Ecuador
- Prior art keywords
- edulcorant
- oral formulations
- highly dosed
- include ondansetron
- ondansetron
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención proporciona composiciones farmacéuticas de administración oral, caracterizadas por contener sales solubles de ondansetrón y edulcorantes con alto poder endulzante, en proporciones elevadas en relación con el ingrediente activo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0502736-5A BRPI0502736A (pt) | 2005-07-05 | 2005-07-05 | formulações orais de ondansetrona com sabor residual mascarado |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088079A true ECSP088079A (es) | 2008-02-20 |
Family
ID=37604052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008079A ECSP088079A (es) | 2005-07-05 | 2008-01-04 | Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificado |
Country Status (3)
Country | Link |
---|---|
BR (1) | BRPI0502736A (es) |
EC (1) | ECSP088079A (es) |
WO (1) | WO2007003020A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1401086B1 (it) * | 2010-07-19 | 2013-07-12 | Farmalip S R L | Dolcificante. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10109763A1 (de) * | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmazeutische Salze |
AU2002255196A1 (en) * | 2002-04-18 | 2003-10-27 | Dr. Reddy's Laboratories Ltd. | Rapidly dispersing solid oral compositions |
-
2005
- 2005-07-05 BR BRPI0502736-5A patent/BRPI0502736A/pt not_active Application Discontinuation
-
2006
- 2006-02-06 WO PCT/BR2006/000015 patent/WO2007003020A1/en active Application Filing
-
2008
- 2008-01-04 EC EC2008008079A patent/ECSP088079A/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007003020A1 (en) | 2007-01-11 |
BRPI0502736A (pt) | 2007-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011000589A1 (es) | Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer. | |
MY157772A (en) | Antibody formulation | |
EA201290984A1 (ru) | Гелеобразные фармацевтические композиции, препятствующие злоупотреблению | |
BRPI0506779A (pt) | formulação de sorvete, e, sorvete | |
CR20110110A (es) | Composicion farmaceutica | |
GT200800107A (es) | Formulaciones orales que comprenden tigeciclina | |
HN2011003011A (es) | Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas | |
AR080491A1 (es) | Formulaciones orales y sales lipofilicas de metilnaltrexona | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
NO20075111L (no) | Farmasoytisk sammensetning | |
MX2012008717A (es) | Composiciones para el cuidado oral. | |
AR054595A1 (es) | Formulaciones/composiciones farmaceuticas de guanfacina apropiadas para forma de administracion diaria en una unica dosis | |
WO2010021607A3 (en) | Pharmaceutical formulation | |
EA201170512A1 (ru) | Композиция для перорального введения | |
NO20073026L (no) | 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav | |
ECSP10010576A (es) | Formulaciones orales e inyectables de compuestos de tetraciclina | |
CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
IN2012DN00359A (es) | ||
MX2010004899A (es) | Conjugados de neurturina novedosos para uso farmaceutico. | |
TR200806300A2 (tr) | Çözünürlük artırıcı farmasötlk formulasyon | |
TR200900879A2 (tr) | Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler | |
GT200800297A (es) | Formulaciones galenicas de alisquireno e hidroclorotiazida | |
NO20065791L (no) | Asyklovir-formuleringer | |
CO6321223A2 (es) | Formulacion farmaceutica solida que contiene ciclostazol | |
UY29989A1 (es) | Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones |